The outbreak of coronavirus disease 2019 (COVID-19) posed an unprecedented challenge
on public health systems. Despite the measures put in place to contain it, COVID-19 is likely …

As of late 2019, the outbreak of novel coronavirus disease (COVID-19)–that started in China–
has rapidly afflicted all over the world. The COVID-19 pandemic has challenged health-care …

Background: The evidence has shown that SARS CoV-2 infected patients with comorbidities
are more likely to have severe disease sequel and mortality. In SARS-CoV-2 infected cancer …

Abstract The coronavirus disease 2019 (COVID-19) is caused by the newly discovered
SARS-CoV-2. Hematopoietic stem cell transplantation (HSCT) is a high-risk procedure. The …

Background: The insistent range of coronavirus (COVID-19) crisis and its permeation into
least developed countries has escalated the bar of countries fragility and susceptibility …

Despite all the extensive research on hematopoietic stem cell cell transplantation (HSCT)
techniques, viral infections as the main factors increase post-transplant mortality. According …

Introduction: The COVID-19 pandemic has challenged hematopoietic stem cell transplant
(HSCT) clinicians to profoundly re-organize their medical care to reduce complications …

Background: Patients undergoing bone marrow transplantation (BMT) are high-risk during
the Coronavirus disease 2019 (COVID-19) outbreak. Viral infections are a common …

Despite all the extensive research on hematopoietic stem cell cell transplantation (HSCT)
techniques, viral infections as the main factors increase post-transplant mortality. According …

Despite all the extensive research on hematopoietic stem cell cell transplantation (HSCT)
techniques, viral infections as the main factors increase post-transplant mortality. According …